Cargando…
Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience
INTRODUCTION: Transfusion transmitted infections (TTIs) can cause threat to bloody safety as blood transfusion is an important mode of transmission of TTI to the recipient, hence, to prevent transmission of these diseases, screening tests on blood bags is an important step for blood safety. AIM: Thi...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607759/ https://www.ncbi.nlm.nih.gov/pubmed/28966492 http://dx.doi.org/10.4103/0974-2727.214246 |
_version_ | 1783265332890173440 |
---|---|
author | Chandekar, Sushama A. Amonkar, Gaythri P. Desai, Heena M. Valvi, Nitin Puranik, Gururaj V. |
author_facet | Chandekar, Sushama A. Amonkar, Gaythri P. Desai, Heena M. Valvi, Nitin Puranik, Gururaj V. |
author_sort | Chandekar, Sushama A. |
collection | PubMed |
description | INTRODUCTION: Transfusion transmitted infections (TTIs) can cause threat to bloody safety as blood transfusion is an important mode of transmission of TTI to the recipient, hence, to prevent transmission of these diseases, screening tests on blood bags is an important step for blood safety. AIM: This study was undertaken with the aim of determining the seroprevalence of TTI in healthy blood donors in a tertiary care blood bank. MATERIALS AND METHODS: A retrospective study was carried out over a period of 5 years from January 2007 to December 2011. Serum samples were screened for hepatitis B surface antigen (HBsAg), antibodies to human immunodeficiency virus (HIV) Type 1 and 2, hepatitis c virus (HCV) and syphilis using enzyme-linked immunosorbent assays with the third generation kits and venereal disease research laboratory test, respectively. RESULTS: A total of 76,653 healthy donors were included out of which majority of donors were male (91.79%). The overall seroprevalence of HIV, HBsAg, HCV, and syphilis were 0.26%, 1.30%, 0.25%, and 0.28%, respectively. CONCLUSION: Methods to ensure a safety blood supply should be encouraged. For that, screening with a better selection of donors and use of sensitive screening tests including nucleic acid testing technology should be implemented. |
format | Online Article Text |
id | pubmed-5607759 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Medknow Publications & Media Pvt Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-56077592017-10-01 Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience Chandekar, Sushama A. Amonkar, Gaythri P. Desai, Heena M. Valvi, Nitin Puranik, Gururaj V. J Lab Physicians Original Article INTRODUCTION: Transfusion transmitted infections (TTIs) can cause threat to bloody safety as blood transfusion is an important mode of transmission of TTI to the recipient, hence, to prevent transmission of these diseases, screening tests on blood bags is an important step for blood safety. AIM: This study was undertaken with the aim of determining the seroprevalence of TTI in healthy blood donors in a tertiary care blood bank. MATERIALS AND METHODS: A retrospective study was carried out over a period of 5 years from January 2007 to December 2011. Serum samples were screened for hepatitis B surface antigen (HBsAg), antibodies to human immunodeficiency virus (HIV) Type 1 and 2, hepatitis c virus (HCV) and syphilis using enzyme-linked immunosorbent assays with the third generation kits and venereal disease research laboratory test, respectively. RESULTS: A total of 76,653 healthy donors were included out of which majority of donors were male (91.79%). The overall seroprevalence of HIV, HBsAg, HCV, and syphilis were 0.26%, 1.30%, 0.25%, and 0.28%, respectively. CONCLUSION: Methods to ensure a safety blood supply should be encouraged. For that, screening with a better selection of donors and use of sensitive screening tests including nucleic acid testing technology should be implemented. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5607759/ /pubmed/28966492 http://dx.doi.org/10.4103/0974-2727.214246 Text en Copyright: © 2017 Journal of Laboratory Physicians http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Chandekar, Sushama A. Amonkar, Gaythri P. Desai, Heena M. Valvi, Nitin Puranik, Gururaj V. Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience |
title | Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience |
title_full | Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience |
title_fullStr | Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience |
title_full_unstemmed | Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience |
title_short | Seroprevalence of transfusion transmitted infections in healthy blood donors: A 5-year Tertiary Care Hospital experience |
title_sort | seroprevalence of transfusion transmitted infections in healthy blood donors: a 5-year tertiary care hospital experience |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607759/ https://www.ncbi.nlm.nih.gov/pubmed/28966492 http://dx.doi.org/10.4103/0974-2727.214246 |
work_keys_str_mv | AT chandekarsushamaa seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience AT amonkargaythrip seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience AT desaiheenam seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience AT valvinitin seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience AT puranikgururajv seroprevalenceoftransfusiontransmittedinfectionsinhealthyblooddonorsa5yeartertiarycarehospitalexperience |